A narrative review of cardiac lymphoma in Africa: diagnostic challenges, treatment outcomes, and future perspectives

Cardiac lymphomas, while rare, present distinct clinical and diagnostic challenges within the African healthcare context. This narrative review synthesizes current evidence on cardiac lymphomas in Africa, with emphasis on epidemiological patterns, clinical manifestations, diagnostic limitations, and treatment strategies. A comprehensive synthesis of the literature affirms that primary cardiac lymphomas remain exceedingly rare across the continent, while secondary cardiac involvement, particularly from high-grade non-Hodgkin lymphomas such as Burkitt lymphoma, appears more frequently. Clinical presentations are heterogeneous but commonly mimic heart failure, with dyspnea being the most prevalent symptom. Diagnostic challenges are pervasive due to limited access to advanced imaging modalities; echocardiography and chest radiography, though widely used, frequently yield non-specific findings. The high burden of human immunodeficiency virus (HIV) infection significantly influences the disease profile, driving the predominance of aggressive B-cell lymphomas. Therapeutic interventions, primarily based on CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) or R-CHOP (with the addition of Rituximab) chemotherapy regimens, are generally adapted from international guidelines; however, their implementation is constrained by systemic limitations, including resource availability and healthcare infrastructure. Prognosis is influenced by the extent of myocardial involvement, comorbid conditions, and critical socioeconomic factors such as treatment affordability. Although infrequent, cardiac lymphomas constitute a critical clinical entity in Africa, necessitating increased awareness and targeted strategies. Strengthening diagnostic capacity, developing context-specific treatment algorithms, and fostering regional research collaborations are essential to improve outcomes and inform evidence-based management in resource-limited settings.

Authors

Institutions

Publication Details

Journal
Cardiology Plus
Published
2025-10-01
DOI
https://doi.org/10.1097/cp9.0000000000000137
Primary Topic
Cardiac tumors and thrombi
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A narrative review of cardiac lymphoma in Africa: diagnostic challenges, treatment outcomes, and future perspectives

Toluwalase Awoyemi, Kayode Emmanuel Ogunniyi, Olufolake O. Odufuwa, Gbolahan Olatunji et al.
Cardiology Plus
Cardiac tumors and thrombi
article

A narrative review of cardiac lymphoma in Africa: diagnostic challenges, treatment outcomes, and future perspectives

Toluwalase Awoyemi, Kayode Emmanuel Ogunniyi, Olufolake O. Odufuwa, Gbolahan Olatunji, Tobi Caleb Olusakin, Nicholas Aderinto, John Olukorode, Yusuf Ismaila Ajayi, Olumide Akinmoju, Peace Ajala, Chidinma I. Udojike, Samuel Owolabi
article en

Abstract

Cardiac lymphomas, while rare, present distinct clinical and diagnostic challenges within the African healthcare context. This narrative review synthesizes current evidence on cardiac lymphomas in Africa, with emphasis on epidemiological patterns, clinical manifestations, diagnostic limitations, and treatment strategies. A comprehensive synthesis of the literature affirms that primary cardiac lymphomas remain exceedingly rare across the continent, while secondary cardiac involvement, particularly from high-grade non-Hodgkin lymphomas such as Burkitt lymphoma, appears more frequently. Clinical presentations are heterogeneous but commonly mimic heart failure, with dyspnea being the most prevalent symptom. Diagnostic challenges are pervasive due to limited access to advanced imaging modalities; echocardiography and chest radiography, though widely used, frequently yield non-specific findings. The high burden of human immunodeficiency virus (HIV) infection significantly influences the disease profile, driving the predominance of aggressive B-cell lymphomas. Therapeutic interventions, primarily based on CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) or R-CHOP (with the addition of Rituximab) chemotherapy regimens, are generally adapted from international guidelines; however, their implementation is constrained by systemic limitations, including resource availability and healthcare infrastructure. Prognosis is influenced by the extent of myocardial involvement, comorbid conditions, and critical socioeconomic factors such as treatment affordability. Although infrequent, cardiac lymphomas constitute a critical clinical entity in Africa, necessitating increased awareness and targeted strategies. Strengthening diagnostic capacity, developing context-specific treatment algorithms, and fostering regional research collaborations are essential to improve outcomes and inform evidence-based management in resource-limited settings.

Cardiology PlusVol. 10(4)
Northwestern University (US), Montefiore Medical Center (US), University of Ilorin (NG), University of Ibadan (NG), University of Lagos (NG), Richmond University Medical Center (US), Babcock University (NG), Mount Sinai Medical Center (US), Lagos State Health Service Commission (NG), Ladoke Akintola University of Technology (NG), Obafemi Awolowo University (NG), Michigan State University (US)
Industry, innovation and infrastructure
Openalex Percentile: Top 30%
Cardiac tumors and thrombi
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.